fig3
![Amyloid-β-targeted therapies for Alzheimer's disease: currently and in the future](https://image.oaes.cc/fc61c46e-cad6-4066-8621-09e8287bafb1/and3016.fig.3.jpg)
Figure 3. Amyloid-β (Aβ) epitopes of anti-Aβ vaccines and monoclonal antibodies tested in clinical trials for Alzheimer’s disease. Aβ amino acid sequence is indicated in the one-letter code. Anti-Aβ vaccines and monoclonal antibodies are classified according to the targeting epitope of Aβ. Aβ: amyloid-β.